Login to Your Account

Israel's Entera Bio goes after U.S. listing in $50M IPO

By Marie Powers
News Editor

Friday, November 10, 2017

Entera Bio Ltd., established in June 2010 as a joint venture of fellow Israeli firms DNA Biomedical Solutions and Oramed Pharmaceuticals Inc., is seeking to raise up to $50 million, including overallotments, in an IPO, with a listing on Nasdaq under the ticker ENTX.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription